TULIP: A New Approach to IOP Reduction - Takeaway - MDSpire
Feature

TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.

Share

  • 1

    TULIP: noninvasive ultrasound device for lowering IOP.

  • 2

    Aims to improve glaucoma management without tissue damage.

  • 3

    Early studies show approx. 25.8% IOP reduction.

  • 4

    No significant side effects or complications noted.

  • 5

    Bilateral IOP reduction suggests neuro-autonomic influences.

  • 6

    Addresses challenges of medication adherence.

  • 7

    Potential role in early disease management.

  • 8

    Future studies needed for long-term effectiveness.

Original Source(s)

TULIP: A New Approach to IOP Reduction

  • by Donald Schwartz, MD

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.